Month: September 2019

Blue Horseshoe Stocks: ARDX Recap, Options Ideas

Ardelyx, Inc. ARDX

We selected ARDX yesterday morning for inclusion in our daily extended watchlist, and to be perfectly honest, our timing couldn’t have been much better. The stock exploded out of the gate, and despite a down day for the markets at large, ARDX bucked the trend with its biggest single session move since 2017.

The stock managed an intraday range of 3.77-5.95 which works out to a daily gain of 58% The stock ended the session with a bullish close 5.82, losing very little of its gained ground  That puts it in the class of possible momentum mover, so we’ll certainly continue to keep our eyes peeled for further gain opportunities.

PVH Corp. PVH

Following an earnings beat last week for the owner of the once extremely popular Tommy Hilfiger clothing brand, PVH has been making attempts to come up off of its bottom for a few sessions. Today, we’ve spotted a $10M Form-4 buy from the CEO, and coupled with the positioning of the chart, we would like to signal an options idea for the chain.

Taking all of the current circumstances into account, we are going to be tracking the PVH 09/20 $75-85 Calls, in the days and weeks to come.

Bonus Idea:
SPY Weekly 292-293.50 Calls 

Extended Watchlist: 
OPGN, MIK, PFSI, TBLT, RKDA, PFSI, PVH, KMPH,

Blue Horseshoe Stocks: SRPT Bottom-Watch

Ulta Beauty, Inc. ULTA

Before we broke for the holiday weekend on Friday, we designated a last minute bearish options idea for ULTA in our premarket report, and thanks to a lackluster day for stocks in general as the markets fell, we saw some nice gains out of those plays, which were the ULTA Weekly $265-260 Puts..

The company also had reported and missed on earnings, receiving multiple analyst downgrades to add fuel to the fire. All of those elements converged to make for the following possible gains for anyone who had caught our alert in the morning.

The $265 Puts traded up from a low of 12.30 and more than doubled as they ran to 26.46 for an intraday move of 115%  The $260’s posted an even bigger gain, running form 7.40-19.90, which worked out to a total possible profit of 169%

Sarepta Therapeutics, Inc. SRPT 

We want to take a look at SRPT as we kick off this short trading week, and form an extended term idea. The stock is heavily oversold at present time as it searches out a bottom, and we would like to be ready and waiting when what we feel is an imminent recovery begins.

There is also a massive topside gap on the SRPT chart that could give the stock even more breathing room when it finally makes its reversal and begins to trend up again. We are going to give ourselves plenty of time on this one, signaling the SRPT 10/04 $91.50-94 Calls to watch in coming weeks.

Extended Watchlist:
VIVE, ARDX, GGAL, TBLT, BNGO, SUPV, TBLT, PGSY